ACERUS PHARMACEUTICALS CORPORATION

ACERUS PHARMACEUTICALS CORPORATION

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime u... rinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.

Acerus Pharmaceuticals Corporation_logo

Industry:
Corporation

Address:
2486 Dunwin Drive, Mississauga, ON, Canada Zipcode L5L 1J9

Country:
Canada

Phone:
416 679 0771

Market Cap:
76.88M
Total Revenue:
1.08M
Total Assets:
16.98M
Total Cash:
9.15M

CEO: Edward Gudaitis


Key Executives
Name Title Pay Year Born
Mr. Edward Gudaitis Pres, CEO & Director 189,915$ N/A
Mr. Robert M. Motz Chief Financial Officer 185,249$ N/A
Mr. Philippe Savard VP, Gen. Counsel & Corp. Sec. 175,972$ N/A
Mr. Gavin Damstra Sr. VP of International Commercial 156,856$ N/A
Mr. Chris Witty Investor Relations N/A N/A
Dr. Christopher Sorli Ph.D., M.D., F.A.C.E. Chief Medical Officer N/A N/A
Mr. Kevin Thomas Hickey Sr. VP of US Commercial N/A N/A
Mr. Hubert Tomasz Czerwinski Pres of Acerus Pharmaceuticals SRL N/A N/A



Financial & Stock
Exchange Toronto. Currency in CAD. Market state CLOSED
According to Acerus Pharmaceuticals Corporation's financial reports the company's revenue in 2020 were 1.08M an decrease(-66.67%) over the years 2019 revenue that were of 3.77M. In 2020 the company's total earnings were -24.42M while total earnings in 2019 were -16.13M( +50%).
Company's stock symbol is ASP.TO. Lastest price : 0.0500. Total volume :218.40k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.aceruspharma.com

Unable to get host informations!!!

Loading ...
Loading ...


More informations about "Acerus Pharmaceuticals Corporation" on Search Engine

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com Acerus is a specialty pharmaceutical company focused on the commercialization and development of innovative products that improve the patient experience.

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com Acerus is a Canadian-based specialty pharmaceutical company focused on …

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com We are always looking for the brightest and best talent to join our team. If you have the …

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com Mr. Motz serves as the Chief Financial Officer of Acerus Pharmaceuticals Corporation. He …

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com At Acerus, we are dedicated to offering innovative solutions in Men’s Health. The …

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com On September 8, 2015, the name of the Corporation was formally changed from …

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com ESTRACE® and the ACERUS PHARMA logo are trademarks of Acerus Pharmaceuticals …

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com Acerus is a Canadian-based pharmaceutical company focused on the commercialization …

Acerus Pharmaceuticals Corporation - Home

Aceruspharma.com Acerus applies proprietary drug delivery technology platforms to existing molecules, …

Acerus Pharmaceuticals Corporation - News

Aceruspharma.com ESTRACE® and the ACERUS PHARMA logo are trademarks of Acerus Pharmaceuticals Corporation. NATESTO® name and logo are trademarks of Acerus Biopharma Inc., used under ...

Acerus Pharmaceuticals Corporation - Acerus Announces

Aceruspharma.com Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health.

ACERUS PHARMACEUTICALS CORP (ASPCF) Stock Price, News

Finance.yahoo.com About Acerus Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that...

Acerus Pharmaceuticals - Overview, News & Competitors

Zoominfo.com Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescript...

Acerus Pharmaceuticals Corp (ASP-T) Quote - The Globe and Mail

Theglobeandmail.com Acerus Pharmaceuticals Corp is a specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men's and women's...

Bullboard for Acerus Pharmaceuticals Corp - Stockhouse

Stockhouse.com Mar 18, 2021 · Acerus Pharmaceuticals Corp is a specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men's and women's health. The company markets its product under …

Acerus Pharma | LinkedIn

Linkedin.com Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that...

Baystreet.ca - Acerus Pharmaceuticals Corporation

Baystreet.ca Apr 01, 2021 · Following early growth in the specialty segment, assuming full ownership of NATESTO fulfills Acerus’ mission to build and leverage a robust commercial business unit in the U.S. Acerus...

ASPCF: Acerus Pharmaceuticals Corporation - Stock Price

Cnbc.com Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a Canada-based pharmaceutical company. The Company is engaged …

Acerus Pharmaceuticals Corporation Company Profile

Dnb.com Acerus Pharmaceuticals Corporation is located in Mississauga, ON, Canada and is part of the Drug Wholesalers Industry. Acerus Pharmaceuticals Corporation has 19 total employees across all of its locations and generates $3.77 million in sales (USD).

Acerus Pharmaceuticals Corporation (ASP) | Stock Price

Money.tmx.com Apr 03, 2021 · Get the latest stock price for Acerus Pharmaceuticals Corporation (ASP), plus the latest news, recent trades, charting, insider activity, and analyst ratings.

Acerus Pharmaceuticals (TSX:ASP) - Share price, News

Simplywall.st Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men’s and women’s health.

ASP:Toronto Stock Quote - Acerus Pharmaceuticals Corp

Bloomberg.com Acerus Pharmaceuticals Corporation operates as pharmaceutical development company. The Company produces therapeutics for the treatment of male hypogonadism, female sexual dysfunction, and …

ASPCF Stock Price | Acerus Pharmaceuticals Corp. Stock

Marketwatch.com Acerus Pharmaceuticals Corp. engages in the development, manufacture, production, marketing, and distribution of women's and men's health products. It focuses on therapeutics for urology, hormone ...

ACERUS PHARMACEUTICALS CORP (ASP.TO) Stock Price, News

Finance.yahoo.com About Acerus Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that ...

Baystreet.ca - Acerus Pharmaceuticals Corporation

Baystreet.ca Mar 26, 2021 · Acerus Pharmaceuticals Corporation shares T.ASP are trading unchanged at $0.06. Stocks in Play. MTY Food Group Inc. 4/9/2021 12:10 PM …

Acerus Pharmaceuticals Corporation Profile

Sedar.com Acerus Pharmaceuticals Corporation: Mailing Address: 2486 Dunwin Drive Mississauga, Ontario L5L 1J9: Head Office Address: 2486 Dunwin Drive Mississauga, Ontario L5L 1J9: Contact Name: Philippe P. Savard: Principal Regulator: Ontario: Business e-mail address: [email protected]: Short Form Prospectus Issuer: Yes: Telephone Number: 647 793 ...

Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis

Seekingalpha.com Mar 11, 2021 · Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q4 2020 Earnings Conference Call March 11, 2021 10:00 AM ET. Company Participants. Bob Motz - Chief Financial Officer. Ed Gudaitis …

ASP-CA: Acerus Pharmaceuticals Corporation - Stock Price

Cnbc.com Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a Canada-based pharmaceutical company. The Company is engaged …

Acerus Pharmaceuticals Corporation (ASP) | Company Profile

Money.tmx.com Mar 30, 2021 · Acerus Pharmaceuticals Corp is a specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men's and women's health. The company markets its product under …

Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis

Seekingalpha.com Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q3 2020 Results Earnings Conference Call November 3, 2020 10:00 AM ET. Company Participants. Bob Motz - CFO. Ed Gudaitis - …

Acerus Pharmaceuticals Corporation (ASP) | News & Upcoming

Money.tmx.com The latest news and upcoming dividend, earnings, and split events for Acerus Pharmaceuticals Corporation (ASP).

Stocks in play: Acerus Pharmaceuticals Corporation

Ca.finance.yahoo.com Apr 01, 2021 · Acerus launched promotional efforts to key Urology and Endocrinology specialists in August of 2020. Following early growth in the specialty segment, assuming full ownership of NATESTO fulfills Acerus’ mission to build and leverage a robust commercial business unit in the U.S. Acerus Pharmaceuticals Corporation shares T.ASP are trading ...

Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis

Seekingalpha.com Aug 11, 2020 · Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q2 2020 Earnings Conference Call August 11, 2020 10:00 AM ET. Company Participants. Bob Motz - CFO. Ed Gudaitis - President and CEO. Conference ...

Acerus Pharmaceuticals Corporation (ASPCF) Stock Price

Seekingalpha.com Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for …

ASPCF | Acerus Pharmaceuticals Corp. Stock Price & News - WSJ

Wsj.com View the latest Acerus Pharmaceuticals Corp. (ASPCF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Acerus Reports Fourth Quarter and Full Year 2020 Financial

Markets.businessinsider.com Mar 11, 2021 · Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient ...

ACERUS PHARMACEUTICALS CORP (ASP.TO) Stock Price, News

Ca.finance.yahoo.com About Acerus Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in the ...

Acerus Pharmaceuticals Corporation, ASP:TOR profile - FT.com

Markets.ft.com Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a Canada-based pharmaceutical company. The Company is engaged in the development, manufacture, marketing and distribution of products with a focus on men's health, including urology, and women's health, including hormone replacement therapy and female sexual dysfunction.

Acerus Pharmaceuticals Corporation 2486 Dunwin Dr

Mapquest.com Get directions, reviews and information for Acerus Pharmaceuticals Corporation in Mississauga, ON. Acerus Pharmaceuticals Corporation 2486 Dunwin Dr Mississauga ON L5L 1J9. Reviews (416) 679-0771 Website. Menu & Reservations Make Reservations . Order Online Tickets ...

Acerus Announces Expansion of NATESTO® Distribution

Markets.businessinsider.com Mar 30, 2021 · Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient ...

ASP Stock Price | Acerus Pharmaceuticals Corp. Stock Quote

Marketwatch.com Apr 01, 2021 · Acerus Pharmaceuticals Corp. engages in the development, manufacture, production, marketing, and distribution of women's and men's health products. The …

Press Release Distribution and Management

Globenewswire.com TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its fourth quarter and full year 2020 financial and operating results on ...

ACERUS PHARMACEUTICALS CORP (ASPCF) Company Profile

Finance.yahoo.com Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for …

Acerus Announces Expansion of NATESTO® Distribution Worldwide

Finance.yahoo.com Mar 30, 2021 · About Acerus. Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization …

Acerus Pharmaceuticals Corporation, ASP:TOR summary - FT.com

Markets.ft.com Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a Canada-based pharmaceutical company. The Company is engaged in the development, manufacture, marketing and distribution of products with a focus on men's health, including urology, and women's health, including hormone replacement therapy and female sexual dysfunction.

ASP | Acerus Pharmaceuticals Corp. Stock Price & News - WSJ

Wsj.com View the latest Acerus Pharmaceuticals Corp. (ASP) stock price, news, historical charts, analyst ratings and financial information from WSJ.

ACERUS PHARMACEUTICALS CORPORATION : Stock Market News …

Marketscreener.com ACERUS PHARMACEUTICALS CORPORATION: Veröffentlichung des Halbjahresergebnisses: 2018: ACERUS PHARMACEUTICALS CORPORATION: publication des résultats semestriels: 2013: TRIMEL PHARMACEUTICALS CORP: publication des résultats trimestriels

Acerus Pharmaceuticals Corporation (ASPCF) CEO Edward

Seekingalpha.com Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q2 2019 Earnings Conference Call August 7, 2019 8:30 AM ET. Company Participants. Robert Motz - Chief Financial Officer. Edward Gudaitis ...

Have Insiders Been Buying Acerus Pharmaceuticals

Simplywall.st Mar 12, 2021 · So we'll take a look at whether insiders have been buying or selling shares in Acerus Pharmaceuticals Corporation . What Is Insider Buying? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, rules govern insider transactions, and certain disclosures are required.

ACERUS PHARMACEUTICALS CORPORATION ANNUAL …

S2.q4cdn.com Mar 04, 2019 · 100% of the common shares of the Corporation (the “Acerus Common Shares”). On September 8, 2015, the name of the Corporation was formally changed from “Trimel Pharmaceuticals Corporation” to “Acerus Pharmaceuticals Corporation”. On July 19, 2011, the Corporation’s common share s were delisted from the TSX -V and graduated and listed

ACERUS PHARMACEUTICALS CORP (ASP.TO) Latest Stock News

Finance.yahoo.com Get the latest ACERUS PHARMACEUTICALS CORP (ASP.TO) stock news and headlines to help you in your trading and investing decisions.

Acerus Announces Expansion of NATESTO® Distribution

Marketscreener.com Mar 30, 2021 · Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health.

Trimel Pharmaceuticals Corp. - ASPCF - Stock Price Today

Zacks.com Mar 19, 2021 · Acerus Pharmaceuticals Corporation is a pharmaceutical company. The company is focused on the development, manufacture, marketing and distribution of …

Acerus Pharmaceuticals Corp. to Host Earnings Call

Finance.yahoo.com Mar 11, 2021 · NEW YORK, NY / ACCESSWIRE / March 11, 2021 / Acerus Pharmaceuticals Corp. (TSX:ASP) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to …